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The hamster flank organ is a widely used model of the 
control of sebaceous gland activity by androgens and 
anti-androgens. Finasteride, a Sa-reductase inhi-
bitor, was administered locally on the surface of 
the right flank organ and right ear twice daily for 4 
weeks. The treatment caused similar 12% to 30% 
reductions in the size of the sebaceous glands in both 
flank organs. Moreover, relative mRNA levels of the 
androgen-regulated FAR-17a gene measured by in 
situ hybridization as well as [3H]-thymidine incorpo-
ration and Sa-reductase activity were similarly de-
creased in the two flank organs after topical applica-
tion. The pure anti-androgen flutamide, at the same 
doses, exerted a more potent effect on all the same 
parameters, and the effect was also comparable on 
I t is well recognized that acne, seborrhea, hirsutism, and androgenic alo pecia are associated with excess androgens an d that, moreover, the skin syn thesizes androgens from in active stero id precursors [1-6]. In fa ct, in creased loca l biosynthesis of Sa-dih yd rotestosteron e (DH T ), the m ost 
potent androgen, &om the weaker androgen testoste ron e by the 
enzyme Sa-redu ctase h as been suggested to be o ne of the m ech a-
nism s invo lved [7] . Because androgens p lay such an impo rtant ro le 
in th e e tio logy of these common diseases, the disco very o f loca lly 
e ffective anti-andt·ogens o r androgen antagon ists wou ld be of maj o r 
interest. M any compounds ha ve been in vestiga ted iJl laboratory 
experime nts and in clinica l trial s, includin g spiro no lactone [8], 
cyproterone acetate [9], 17a-m ethyl-B-n o rtestosterone [10] , and 
Autamide [11]. T he pro bl em with these compounds is their sys-
tem ic action , whereby these drugs might, among othe r e ffects, 
reduce libido and impair spermatogen esis in m en and feminize mal e 
fetuse s in pregnant wo m en. It is thus important to m ake available a 
compo und that co uld exe rt loca l activity in the skin and its 
appendages afte r to pica l applica ti o n w ithout ca usin g the above 
systemic side effects. 
T h e Aank o rgans in the ham stet· are oval, darkl y p igm en ted 
structures located in the costoverte bra l region tha t consist mainly of 
large sebaceous g lands and hair follicles. T he development, growth, 
and secretion of these g lands are highl y regulated by androgens, 
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both the treated and untreated sides of flank organs. 
Finasteride and flutamide significantly decreased 
ventral and dorsal prostatic weights after topical 
application. The present data show that the topical 
administration of finasteride, in analogy with flut-
amide, causes local inhibition of sebaceous gland 
growth in both the costovertebral organs and ears. 
However, as demonstrated by the similar inhibitory 
effect in the contralateral untreated side and the 
reduced weight of the dorsal and ventral lobes of the 
prostate and seminal vesicles, finasteride and flut-
amide both exert significant systemic effects. Key 
JVords: Sa-reductase inhibitot'!andr,ogeus!costover,tebral or'-
ganlsebaceous glands/mrti-andl'ogeuJFAR-17 a geue. J Iuvest 
Demratol 105:678-682, 1995 
and this animal mode l ha s been widely used to investigate the 
ac tivity of anti-androgeni c compounds [1 2-1 S]. Simila rly, the skin 
of the inn e r ea r lo be contains a dense layer of seba ceous g lands that 
are a lso hjghl y sensitive to androgens [1 6 -1 8]. 
Finasteride (MK-906, Proscar, N-[1 ,1 -dimcthyl-e thyl]-3- oxo-4-
aza- Sa-androst-1-ene-17 J3-carboxamide) is a specifi c inhibitor of 
testoste rone Sa-reductase without bindin g to the androgen recep-
tor in the rat, dog, m on key, and human [1 9,20] . In this study, 
finastcride w as administered topically on the right Aank o rgan and 
ear of the golden Syrian hamster. Besides m o rpho m etric and 
histologic eva luatio n , namely size o f the sebaceous g lands and 
( 3 H]-thymidin e in corpo ra tio n in th e sebaceous g land cell s, we also 
m easured the re lative levels of FAR-l7a ml~A by ;, s iltl hybrid-
izati on . T hjs gene , which was fi rst iso lated and characterized by 
Seki cl nl (21], is hjghl y sensitive to androgen s and is expressed at a 
hig h level in the ham ster Aank o rgan . Castratio n causes a marked 
decrease in the levels of FAR-17a mRNA within a few days to 
undetecta bl e levels, wh ereas topica l appli cation of testosterone and 
dih ydro testosteron e fu ll y restores mi~A leve ls [22]. T he do t-blot 
hybridi za ti on data o btain ed were, however, semiquantitative, and 
the m easurem ent of FAR-17a mRNA levels by;, sit11 hybridization 
in hamste r flank o rga n was n o t perfo rm ed. We thus compared the 
effects of finasteride on the above-mentioned parameters with the 
e ffects of the an ti-androgen Au ta mide, which is a lready known to 
affect so m e of these param eters [1 3] . 
MATERJALS AND METHODS 
Animals Male adult Syrian hamsters (11 0-120 g) were purchased from 
Charles l~ver Laboratories (St. Constant. Q uebec, Canada) and housed five 
per cage in cxpcrin1 cn t 1 and o ne anin1a l per cage in cxpcrin1cn t 2 in a 
light-controlled (14-h bght/ d) and temperature-controll ed (22 :!: 1 oq 
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environment. The animals were ho used in plastic boxes on sawdust and had 
ad libitum access to hamster chow (Agway Country Food Inc. , Syracuse, 
NY) and tap water. 
Finasteride and Flutamide Finastel'idc was synthesized in our medici-
nal c hemistry division following the synthetic approach of Rasmusson et n/ 
[23]. The compound was at least 98% pure by high-performance liquid 
chromatography. Flutamide was kindl y provided by Dr. R. Neri (Schering-
Plo ugh Laboratories, Kenilworth , NJ) . 
Experimental Procedures In cxpcrin1 cnt 1 , the han1stcrs ·were ran-
domly di vided into seven gro ups: intact controls; 30, 100, and 300 IJ-g of 
finas tel'idc; and 30, 1 00, and 300 IJ-g of Autamidc. At the beginning of the 
expel'iment, the car was marked fo r identifi cation purposes and the area of 
the flank organ was shaved with anima l clippers. T he appro priate doses of 
finasteride and Autamidc were di sso lved in SO'X• ethanol-50% propylene 
glycol (vollvol), and ·1 0 !J-I was administered on the right side of the hamste r 
Aank organs as wel l as on the right ca rs. Meanwhile, the intact group and 
the left sides o f the Aank organs and cars of the finastcridc- and Autamide-
created groups received the vehicle onl y. To examine the possibility of ora l 
in ta ke of fina stcridc because of the hamsters ' grooming. we perfo rmed :111 
exp eriment comparing the activ ity of the 1 00-!J-g dose of fina stcride in a 
group of an imals in which the Aank organ was covered with micropore 
surgical tape and another group in which the right Aank organ was le ft 
uncovered . 
The animals were killed by decapitation. The Aank organs and cars were 
removed quickly and fixed for histologic examination and iu situ hybridiza-
tion, or frozen in dry ice and stored at - 80°C for enzymatic assays. The 
ventral and dorsal lobes of the prostate as well as the seminal vesicles were 
removed, di ssec ted , fl·eed fi·om f.1t and connective tissue, and rap idly 
weighed. The ventral lobes of the prostate and the testes were frozen and 
kept at -80°C. 
Measurement of the Size of Sebaceous Glands The pieces of Aank 
organs and ears were fixed in 4% paraformaldehyde for 48 h (1-2 h for 
hybridization) and then rinsed in 15% sucrose phosphate buffer for 24 h (30 
min for hybridization) at 4 °C. The tissues were then embedded in Tissue-
tek (Miles Inc. , Diagnostics Division , Elkhart, IN) and cut with a cryos tat 
into 8-~J-m-thi ck sections before staining with hematoxylin and eosin. The 
surface areas of the sebaceous glands of Aank organs were drawn on the 
photographs with a graphics tablet (Hewlett-Packard 9111 A graphics 
cable c) , and the surface areas of the sebaceous glands of the cars were 
estin1ated directly under optical microscopy using a grid. T he results were 
calculated in units and expressed as percentages, while the control gro up 
taken as 100%. 
Preparation of eDNA Probe The 474-base-pair eD NA insert used in 
tllis study was obtained by amplifYing part of the nucleo tide sequence of the 
FA1~-17a eDNA, as described by Sek:i et nl [21]. T he fi·agment was radiolabeled 
with [a-35S] dCTP (Amersham, Oakville. Ontario, Canada; > 3000 Ci/ mmol) 
by random pl'imer method [24) to high specific activity (1 09 dpm/ IJ.g). 
Measurement of FAR-17a mRNA Levels by Iu Situ Hybridization 
Tissu e preparation was the same as described above for measurement of the 
size of the sebaceous glands. Frozen sections. on the other hand , were 
mounted on gelatin- and polylysine-coated slides and kept at - 80°C until 
hybridization. On the day of hybridization, the samples were acc tylated 
wid1 0 .25'Yo ace ti c anh ydride in 0.1 M triethanolamine (pH 8.0) for 10 min 
before immersion in 2 X standard sa line citrate for 1 0 min. Prehybridization 
was performed as described prev iously [25). For hybridi za tion. 2 X ·1 06 cpm 
hear-denatured [35S]-labeled FAK-17a eDNA pro be was used. The tissue 
specificity of the probe was ascertained by hybridizing sections fi·om 
hamster kidney, liver, testis. and spleen with the FAR.-1 7a eDNA probe. No 
specific hybridization could be observed. Densitometric measurement of 
autoradiographs of Aank organs from all experimental groups was per-
formed using a Bioimage analysis system , and the mean optica l in tensity 
value per mm2 of labeled areas for each section was thus ca lculated. 
[ 3H] -Thymidine Incorporation Two and one-half hours before the 
hamsters were killed , 10 !J-C i [methyl-31-1]-thymidine (82 C i/ mmol , Amer-
sham) was diluted in 100 !J.I 0.9% NaC I and loca ll y injected subcutaneously 
into the Aank organs. Six 7-~J-m-thick consecutive paraffm sec tions were 
prepared for each specimen. Deparaffini zed sections were then coated with 
a liquid photographic emulsion (Kodak NTB-2; Eastman Kodak, Roches-
ter, NY) and exposed to autoradiography for 3 weeks. The sections were 
then processed and stained w ith hematoxylin and eosin. The total number 
oflabeled basal cells was counted under optical microscopy for each section, 
and the means of six consecutive sections were calculated for each Aank 
organ. The results arc expressed as a percentage of change, with the total 
numb er of labeled cells in the control group set at 100%. 
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Figure 1. Effect of topical application of finasteride or flu tam ide at 
doses of 30, 100, or 300 JJ.g on the right flank organ and ear on the 
sebaceous gland area of the flank organs in intact tnale hamsters. 
The units of the control gro up were set at 100%. The data arc presented as 
mean ::!: SEM (n = 8). +p < 0.05; ++ p < 0.0 1 versus left (L) side of intact 
animals. *p < 0.05; **p < 0.01 versus right (R) side of in tact conu·ols. 
Enzytnatic Assays Measurement of 3/3-hydroxys tero id dehydrogenase 
(HSD). 17 !3-HSD. and Sa-reductase activities was perfo rmed as described 
prev io usly [26]. 
Statistical Analysis Statistical signifi cance was measured according to 
the multiple-range test of Duncan-Kramer [27). Data are expressed as mean 
::!: SEM. 
R ESULTS 
Figure 1 sh ows changes in the size of the unde rlying seb aceous 
g lands of Rank organs from animals th a t receive d in c reasing doses 
of finasteride or Rutamide. Treatment w ith fin asteride with the 
30-J.Lg dose caused a 15.9% re du ction (p < 0.05) o n the le ft side and 
a 12.4% reduc tion (not significant) on the right side compare d with 
the intac t control group. At the l 00-J.Lg dose, a 16.7% reduc tio n 
was observed in the Rank organ s of both sides (p < 0 .05) . A 29 .9% 
decrease (p < 0.01) on the le ft side and a 29.4'X• d ecrease (p < 0.01) 
on the right side were observed at the 30-JJ.g d ose. On the other 
hand, the 300-J.Lg dose of Rutamide caused a maximum decrease of 
52 .0% (p < 0.01) o n the left side and 52.5% (p < 0.01) on th e ri g ht 
side in the Rank organs . Simil ar results w e re obtained in t h e ears. In 
fact, trea tment w ith fina stcride caused 19.7% (p < 0.05), 23. 1% 
(p < 0 .01), and 30.7% (p < 0.01) decreases in th e car sebaceous 
g land area on the treated side and 16.6%, 22.2%, and 26.4% (p < 
0.01) d ecreases on th e contra la teral side after treatment w ith the 
30-, 100-, and 300-J.Lg doses, respective ly. Flucamide , on the oth e r 
hand , caused 30.4°/., , 39.0%, and 67.8% reduction s o n the le ft side 
and 25.2%, 48 .0% , and 67.4% inllibitions on the rig ht side ears (p < 
0.01 for all groups) after tr eatment with the sam e doses. 
As sh own in Fig 2 , the re lative mRNA levels of the androgen-
regulated FAR-17a gene measure d b y i11 sit11 h ybridization were 
inhibited by 2. 7% (not sig nifi cant) , 15.5% (p < 0.05), and 20. 6% 
(p < 0.01) in the left-side Rank organs and b y 1 .1% (no t signifi-
cant), 15 .1% (p < 0.05), and 20.9% (p < 0.01) in the right-side 
Rank o rgans in a dose-de p ende nt manne r (3 0, l 00, and 300 J.Lg, 
respectively) after 4 weeks of treatment with fmasteride . Flutamide, 
on the other h and, caused 14.4% (not sign ifi cant), 24.9% (p < 
0.01), and 34.0% (p < 0.01) inhibition in the le ft-side Rank organs 
and 13 .6% (not significant), 26% (p < 0.01), and 35.5% (p < 0.01) 
inhibitory e ffects in th e rig ht-side Rank organs. 
Figure 3 illustra tes the results of [3 H]-thymidin e incorporation 
into sebaceous g land cells in the Rank organs. This parameter 
indicates the prolife ration of sebocytes and is considered a highly 
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F igure 2. Effect of topical application of finasteride or flutarnide 
on FAR-17a mRNA levels in hamster flank organs. mRNA levels per 
mm 2 of labeled areas were measured by ;, sit11 hybridization using the 
[ 35S]-labeled hamster Rank o rgan FAR-17a eDNA probe. Data arc ex-
pressed as mean :!:: SEM (n = 3) . +P < 0.05; ++ p < 0.01 versus left (L) side 
of intact control s. *p < 0.05; **p < 0.01 versus right (R.) side of intact 
contro ls. 
sensitive parameter of response of the sebaceous glands. Finasteride 
at a dose of 30 J.Lg already decreased the total number of labe led 
cells by 24.4%, (p < 0.01) o n the left side and by 15.0'Vo (p < 0 .01) 
on th e right side compared with the correspond ing control group. 
Inc reasing doses of finasteride led to a progressive decrease in the 
value of thi s parame ter. Reductions of24 .6% (p < 0.01) on the left 
side and 21.5% (p < 0.01) on the right side were achieved with the 
100-J.Lg dose; a 39.6% reduction (p < 0 .01) on the left side and a 
41.6% reduction (p < 0.01) on the right side resulted from 
treatment at the dose of 300 J.Lg. Meanwhile, 300 J.Lg of Autamide 
caused a maximal decrease of 51.2% (p < 0.01) on the left side and 
55.4% (p < 0 .01) on the r ight-side Aank organs . 
Finaste ride ex erts a potent inhibitory effect on Sa-reductase 
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Figure 3. Effect of topical application of increasing doses of 
finasteride or flutarnide on [3H]-tbymidine incorporation in the 
sebaceous glands of hamster flank organs. The tota l number of labeled 
ce ll s was counted in six consecutive sectio ns frorn each fhlnk o rgan. The 
tota l number oflabcled cells in the control group was taken as 1 00'!/o . Data 
are presented as mean :!:: SEM (n = 3) . +p < 0.05; ++p < 0.01 versus left 
(L) side of control group. *p < 0.05 ; **p < 0.01 versus right (R) side of 
control group. 
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Figure 4. Effect of topical application of increasing doses of 
finasteride or flutamide on Sa-reductase activity and 17 /3-HSD 
activity in hamster flank organs. The Sa-reductase activity (wp) was 
measured by the formation of [1 4C]-DHT fi·om (14C]-testoste rone by Rank 
organ homogcnatcs; 17J3-HSD activity (botto111) was measured by the 
formation of [14C]-testostcronc (TESTO) from [1 4C]-~ ·'-dione. Data are 
expressed as mean :±: SEM (n = 6). +"·p < 0.01 versus left (L) side of intact 
controls. ** p < 0.01 versus right (H.) side of in tact controls . 
activity in both treated and untreated hamster Aank organs (Fig 4, 
top). In fact, e ven at the low dose of30 J.Lg twice daily, the decrease 
is highly significant, at 37.5'X, (p < 0.01) on the left side and 54 .7% 
(p < 0 .01) on the right side . At doses of 100 J.Lg and 300 J.Lg , 
treatment with finasteride ca used further decreases by 42.2% and 
51.6"/c, o n the left side and 57 .8% and 61.3% on the right side , 
respectively (p < 0.01 for a ll g roups). Although treatment with 
Autamide had no significant effect at the low dose, the 300-J.Lg dose 
caused a 23.4% decrease (p < 0.05) on the left side and a 42.2% 
decrease (p < 0 .01) in Sa-reductase ac tivity o n the right side. 
Figure 4, botto111 shows 17 ,B-HSD activity in the Aank organs 
after 4 w eeks of treatment with finasteride and Autamide. Finas-
teride caused 34.5% , 27.6%, and 33.3% decreases on the untreated 
left side at 30, 100, and 300 J.Lg, respectively (p < 0 .01 for all 
groups) and 36.2%, 37.4%, and 37.4% decreases OIJ the treated right 
side (p < 0.01 for all grou ps). Flutamide caused som e inhibition 
only at the highest dose u sed , namely a 23.0% decrease (p < 0.05) 
on the left side and a 27.0% inhibition (p < 0.01) on the right side 
at the 300-J.Lg dose. 
It is well recognize d that prostatic and seminal vesicle weights are 
under stringent control by androgens, and these are the most widely 
used models for assessing androgenic and anti- androgenic activity 
[28-30] . As illustrated in Table I, finasteride caused 11.9% (p < 
0.05), 13 .9% (p < 0.05), and 27.5% (p < 0.01) inhibitions in ventral 
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Table I. Effect of Topical Application of Finastel'ide or Flutamide on the Right Flank Organ and Ear on the Weight of 
the Ventral and Dorsal Lobes of the Prostate and on the Setninal Vesicles in httact Male Hamsters" 
Parameters Contro l 30 
Ven t:ra l prostatic 
weight (mg) 48 .1 :±: 2.0 42.4 :±: 1. 51' 
Dorsa l prostatic 
weight (mg) 98.5 :±: 8.4 58.8 :!: 2. 7' 
Sem.i11al vesicle 
weight (mg) 199.5 :!: 5.2 134 .3 :!: 5.1 ' 
11 Dam nrc expressed as me:m ~ SEM (11 = 1 0). 
b p < 0.05. 
' p < 0.0 1. 
Finasteride (!Lg) 
100 
4 1.4 :±: 1. 71' 
53 .9 :!: 1.6' 
127.3 :!: 4 .5' 
prostate weight, whereas flutamide caused a decrease of1S. 7% (p < 
0 .05) at the largest dose used. On the other hand , finaste ride caused 
40 .3 %, 4S.3 %, and 46 .S'Vo inhibitions (p < 0.01 for a ll doses) of 
dorsal prostate w eight, and flutamide caused 17 .S%, 19.4%, and 
25.2% reductions in the value of the same parameter. As shown in 
Table I, finaste ride ca used 32.7%, 36%, and 37.7% inhibitions in 
semina l vesicle weight compared w ith the control group at the 30- , 
100-, and 300-!Lg doses, respectively, whereas 300 !Lg of flutamide 
cau sed a decrease of 19.4%. 
Table II shows the testicular 3J3-HSD, 17J3-HSD, and Sa-
reductase activities afte r 4 weeks of treatment with increasing doses 
of finasteride and flutamide. Finasteride showed no significant e ffec t 
on these parameters except for a SS.9% increase in Sa-reductase 
activity at the 300- !Lg dose, w hereas flutamid e ca used a significant 
increase in the three enzymatic activities , w hich is probably re lated 
to the accompanying increase in serum LH and FSH levels (data not 
shown). 
To avoid the possibili ty of oral absorption of the drugs by the 
ha m sters' groom ing, we pe rformed an experiment in w hich the 
sites of app lica tion were covered . Finasteride and flutamide de-
creased the surf.,ce area of the flank organs and the underlying 
seb aceous g lands as we ll as th e sebaceous glands of the ears on both 
the treated and untreated sides. In fa ct, th e efficacy was simil ar to 
tha t obta ined in the above-described data in w hich the same 
100-fLg twice-daily dose was used. Furthe rmore, as m entioned, 
these two compounds also significantly inhibited the sizes of the 
ventra l and dorsal prostates and seminal vesic les after topica l 
application and inhibi ted Sa -reductase activity in both sides of the 
flank o rgans. AU parameters m easured showed no significant 
dilferences between the un covered g roup and the covered group 
for both finaste ride and flutamide. 
Flutamidc (!Lg) 
300 30 100 300 
34.9 :±: 2.6' 46.0 :!: 2.4 42.6 :±: 2.5 40.5 :!: 1.61' 
52.7 :!: 3 .3' 81.3 :!: 3.3' 79.4 :!: 3.3'' 73.7 :!: 3.6' 
124 .2 :!: 5 .8' 17 1.4 :!: 5.5" 172.8 :!: 5.8' 160.7 :!: 6.8' 
D ISCUSS ION 
T he present data clearly demonstra te th at top ical administration of 
the Sa-redu ctase inhibi tor finasteride significantly decreases the 
size of the sebaceous g lands in hamster flank organs, and this effect 
is accompanied by decreases in ["H)-thymid in e in corporation , th e 
size of the ear sebaceous g lands , and FAR-1 7a mR.NA levels. It is 
w e ll known that hamster flank organs consist of large sebaceous 
g lands, hair fo llicles, and dermal pigment related ro the presence in 
the dermis of dendritic ce lls containing den se structures resembling 
stage IV m elanosom es, and tha t all these compon ents are highl y 
androgen sensitive [31,32). 
An important o bserva tion , however, is char the e ffects observed 
are almost identi cal in bo th the treated and untreated sides of both 
flank o rgans and ears. Such data clearly indicate that fin as te ride is 
absorbed through the systemic circul ation and thu s reaches the 
contralate ral fl ank o rga n as well as other ti ssues . As confirmed in 
the present study, similar resu lts were observed with the an ti-
androgen flutamid e [1 3 ]. 
Tn addition , treatm ent with fin as te t·ide was accompanied by a 
m arked inhibition of Sa -red uctase :1ctivity in both flank organs at 
the lowest dose used, 30 !Lg. It rem ains to be seen , however, 
whether this decrease in Sa-redu ctase activity resu lted ti:o m th e 
inhibition of Sa -reductase gene express ion , p ro tein content, and/ o r 
acti vity, or from fi nasteride remaining in the cells w hen the an im als 
were killed . 
T he presen t study also shows that changes in the levels of 
FAl't-17a mRN A can be quantifi ed by i11 sit11 hybridiza tion. T his 
technique does no t require the extraction o f RNA fi·o m tissue, thus 
cl.iminating an important source of assay va ria tion. Moreover, the 
o bservation of flank organ sections under the light microscope afte r 
Table II. Effect of Topical Application of Finasteride or Fluta1nide on t he Right Flank Organ and Ear on Testicular 
3j3-HSD, 17/3-HSD, and Sa-Reductase Activities in Intact Male Hamsters" 
Finasteridc (!L!;) Flu tamidc (!Lg) 
Testicular Enzym atic 
Activ ity Contro l 30 100 300 30 100 300 
3/3-HSD activity 
(pmol/ mg pro-
tei..n / min) 5.95 :!: 0.4 5.6 :!: 0 .3 6.8 :!: 0.3 6 .3 1 :±: 0.4 7.H :±: 0.6 8.8 :!: 0.91' 13.02 :!: 1.0'' 
17}3-HSD activity 
(nmol/m g pro-
te i.n / min) 0 .1 2 :!: 0. 1 0.13 :±: 0.01 0. 17 :!: 0 .02 0. 18 :!: 0.02 0. 18 :!: 0.0 1 0.22 :!: 0.03 1' 0.27 :!: 0 .04 1' 
Sa-re ductase activ ity 
(pmol/ m g pro-
tein / min) 0.59 :±: 0.08 0.57 :±: 0.06 0.69 :!: 0.05 0. 92 :!: O.Q3" 0.88 :±: 0.08 1' 0. 90 :!: 0.07' 1.1 8 :±: ll.081' 
a Data arc expressed as mean :::!:: SEM (n = 6). 
b p < 0.01 . 
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h ybridization can provide useful info rm ation about cellular local-
ization of the mRNA of interest and allow correlation between 
changes in mRNA content and the gross histologic aspect of the 
tissue . T he availability of i11. sil 11 h ybridization of FAR-17a mRNA 
should facilitate study of the facto rs involved in the control of 
androgen-regul ated gene expression in this tissue and thus help to 
assess the importance of various stero ids and other factors in the 
androgenic regulatio n of Aan k organ activity. 
After o ral administra tion , finaste1icle causes a marked reduction in 
the intra prostatic concentration of DHT and a 2S% to 30% reduction 
in prostatic size in men [33]. Comparable effects were observed in the 
presen t study after topical administration . Ln fuct, the weight of the 
ventra l and dorsal lobes of the prostate as wel.l as that of the seminal 
vesicles was already significantly inhibited at the lowest dose of 
finasteride. Such data, in addition to the action of fmasteride on the 
contralateral Aank organ and ear, show the systemic action of the 
Sa-reductase inhibito r after loca l app lica tion on the skin . 
Harris el nl [34] reported that finasteride has a hig her affinity for 
human prostatic Sa-reductase than for scalp Sa-reductase: the 
concentration of finasteride required to cause 50% inhibiti on in the 
prostatic homogenate was 4.2 nM and in the scalp homogenate SOO 
nM. Recently, two types of Sa-reductase cDNAs w e re isolated in 
the human and rat, and the stru ctures of the corresponding genes in 
the human have been elucidated [3S- 38]. T he som ewhat higher 
sensitivity of the prostate and semin al vesicles than the sebaceous 
glands to the inhibi tory actio n of finasteride observed in the 
hamster could be explain ed by the possible difference in sensitivity 
to the Sa-reductase inhibitor of different ti ssue-specifi c isoenzym es. 
Elucidation of the st ructure of the various types of Sa-reductase 
expressed in the sebaceous glands and the prostate and seminal 
ves icles in the hamster, and stu dy of their enzymatic characteristics, 
should provide an answer to this question . In fact, many reports 
have described the presence of Sa-reductase isoen zym es in both 
rats and humans [39- 41 ]. It should be m entioned that topical 
applicatio n of fi nasteride can reverse the balding process and 
en hance hair regrowth by its inhibition of Sa-reductase in the 
balding stumptai l macaque [ 42]. 
Compounds with systemic action can affect all androgen-sensitive 
organs and functions, for example male sexual differentiation, growth 
and function of the prostate and accessory sex organs in the male, and 
bone form ation and resorption. It is expected that compounds with 
such potential effects from systemic action have limitations in the 
n·eatment of androgen-sensitive abnonnalities such as acne, seboJThea, 
hirsutism, and androgenic alopecia. T he present data demonstrate that 
fu1aste1·ide, at least in the hamster, has significant systemic effects after 
topica l skin administration in relatively smal.l amounts, a charactetistic 
shared by the anti-androgen Autamide. 
IVe i/wuk Ms. Frnure Lepire jill" her skillji1l terllllicnl nssistnuce. 
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